Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts

Autor: Camps Herrero C, Antón Torres A, Cruz-Hernández JJ, Carrato A, Constenla M, Díaz-Rubio E, Feyjoo Saus M, Garcia-Foncillas J, Gascón P, Guillem V

Publikováno v: Journal of Pain Research, Vol Volume 12, Pp 2349-2358 (2019)

Carlos Camps Herrero,1 Antonio Antón Torres,2 Juan Jesús Cruz-Hernández,3 Alfredo Carrato,4 Manuel Constenla,5 Eduardo Díaz-Rubio,6 Margarita Feyjoo Saus,7 Jesus Garcia-Foncillas,8 Pere Gascón,9 Vicente Guillem101Jefe de Servicio de Oncología M

Externí odkaz: https://doaj.org/article/f29c34a74af3471d86758efe8a018135

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Test urinaire PCA3, cancer de la prostate et autres pathologies prostatiques

Autor: Vlaeminck-Guillem, V.

Publikováno v: In Immuno-analyse et biologie spécialisée June 2012 27(3):104-111

Correction: ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors (Clinical Cancer Research (2018) 24 (2517–29) DOI: 10.1158/1078-0432.CCR-17-2904)

Autor: Guerrero-Zotano A. L., Stricker T. P., Formisano L., Hutchinson K. E., Stover D. G., Lee K. -M., Schwarz L. J., Giltnane J. M., Estrada M. V., Jansen V. M., Servetto A., Gavila J. J., Perez-Fidalgo A., Lluch A., Llombart-Cussac A., Bayar M. A., Michiels S., Andre F., Arnedos M., Guillem V., Ruiz-Simon A., Arteaga C. L.

In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::3f2292b9bf192a2e5bede7bad3c3adf2
https://hdl.handle.net/11588/921478

A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms

Autor: Martínez-Laperche C, Buces E, Aguilera-Morillo MC, Picornell A, González-Rivera M, Lillo R, Santos N, Martín-Antonio B, Guillem V, Nieto JB, González M, de la Cámara R, Brunet S, Jiménez-Velasco A, Espigado I, Vallejo C, Sampol A, Bellón JM, Serrano D, Kwon M, Gayoso J, Balsalobre P, Urbano-Izpizua Á, Solano C, Gallardo D, Díez-Martín JL, Romo J, Buño I, GVHD/Immunotherapy Committee of the Spanish Group for Hematopoietic Transplantat

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Blood Advances
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

Despite considerable advances in our understanding of the pathophysiology of graft-versus-host disease (GVHD), its prediction remains unresolved and depends mainly on clinical data. The aim of this study is to build a predictive model based on clinic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb59c5072d83fcd93da0c40e92065d1f
https://doi.org/10.1182/bloodadvances.2017011502